Sinularin markedly suppresses cell growth and induces apoptosis, as well as activate MAPKs and repress PI3K/AKT pathways, which are dependent on ROS generation, thereby exerting anti‐tumor effects against human renal cancer cells.59 The gene discussed is AKT1; the disease is renal carcinoma.